Unison Pharmaceuticals Private Limited — Rivaroxaban Exporter Profile
Indian Pharmaceutical Exporter · #12 for Rivaroxaban · $1.1M export value · DGFT Verified
Unison Pharmaceuticals Private Limited is the #12 Indian exporter of Rivaroxaban with $1.1M in export value and 41 verified shipments. Unison Pharmaceuticals Private Limited holds a 2.1% market share in Rivaroxaban exports across 6 countries. The company exports 4 pharmaceutical products worth $10.6M across 3 therapeutic categories.
Unison Pharmaceuticals Private Limited — Rivaroxaban Export Profile: Buyers & Destinations
Where Does Unison Pharmaceuticals Private Limited Export Rivaroxaban?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $331.3K | 12 | 53.8% |
| MALTA | $168.6K | 6 | 27.4% |
| RUSSIA | $57.1K | 6 | 9.3% |
| CHILE | $19.9K | 3 | 3.2% |
| BELARUS | $19.8K | 11 | 3.2% |
| MALAYSIA | $19.5K | 3 | 3.2% |
Unison Pharmaceuticals Private Limited exports Rivaroxaban to 6 countries. The largest destination is UNITED KINGDOM accounting for 53.8% of Unison Pharmaceuticals Private Limited's Rivaroxaban shipments, followed by MALTA (27.4%) and RUSSIA (9.3%). These destinations reflect Unison Pharmaceuticals Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Rivaroxaban from Unison Pharmaceuticals Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| GMP MANUFACTURING LTD | UNITED KINGDOM | $331.3K | 12 |
| PHARMADOX HEALTHCARE LIMITED | MALTA | $168.6K | 6 |
| TATTY PHARMA LLC | RUSSIA | $57.1K | 6 |
| ASCEND LABORATORIES SPA, | CHILE | $19.9K | 3 |
| BRITITRADE JLLC | BELARUS | $19.8K | 4 |
| ANTAH PHARMA SDN BHD | MALAYSIA | $19.5K | 3 |
| SUNMOON PHARMA LLC | BELARUS | $3 | 7 |
Unison Pharmaceuticals Private Limited supplies Rivaroxaban to 7 buyers globally. The largest buyer is GMP MANUFACTURING LTD (UNITED KINGDOM), followed by PHARMADOX HEALTHCARE LIMITED (MALTA) and TATTY PHARMA LLC (RUSSIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Rivaroxaban Export Value and How Much Does Unison Pharmaceuticals Private Limited Contribute?
India exported $36.7M worth of Rivaroxaban through 5,361 shipments from 221 suppliers to 115 countries, serving 497 buyers globally. Unison Pharmaceuticals Private Limited contributes $1.1M to this total, accounting for 2.1% of India's Rivaroxaban exports. Unison Pharmaceuticals Private Limited ships Rivaroxaban to 6 countries through 7 buyers.
What Is the Average Shipment Value for Unison Pharmaceuticals Private Limited's Rivaroxaban Exports?
Unison Pharmaceuticals Private Limited's average Rivaroxaban shipment value is $26.7K per consignment, based on 41 shipments totaling $1.1M. The largest destination is UNITED KINGDOM (53.8% of Unison Pharmaceuticals Private Limited's Rivaroxaban exports).
How Does Unison Pharmaceuticals Private Limited Compare to Other Indian Rivaroxaban Exporters?
Unison Pharmaceuticals Private Limited ranks #12 among 221 Indian Rivaroxaban exporters with a 2.1% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($12.8M), DR.REDDY'S LABORATORIES LTD ($5.2M), ZENTIVA PRIVATE LIMITED ($3.2M). Unison Pharmaceuticals Private Limited processed 41 shipments to 6 destination countries.
What Rivaroxaban Formulations Does Unison Pharmaceuticals Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| RIVAROXABAN 20 MG FC TABLETS(2X14T)BL (RIVAROXABAN) (2X14)(1NOS=1PACKS) B.NO. 2331055 AS PER INV | $50.0K | 1 |
| RIVAROXABAN 20 MG FC TABLETS(2X14T)BL (RIVAROXABAN)(2X14)(1NOS=1PACKS) B.NO. 2430051,52 AS PER INV | $50.0K | 1 |
| RIVAROXABAN 10 MG FC TABLETS(3X10T)BL (RIVAROXABAN)) B.NO 2431219 & 2431220 (1 NOS=1 PACKS) AS PER INV | $50.0K | 1 |
| RIVAROXABAN 15 MG FC TABLETS(2X14T)BL (RIVAROXABAN) B.NO 2431206, 2431221 & 2431222 (1 NOS=1 PACKS) AS PER INV | $50.0K | 1 |
| RIVAROXABAN 20 MG FC TABLETS(2X14T)BL (RIVAROXABAN)B.NO 2431266,2431267,2431268(1 NOS=1 PACKS) AS PER INV | $50.0K | 1 |
| RIVAROXABAN 20MG FC TABLETS RIVAROXABAN 2X14 T 1 NOS 1 PACK B NO 2530384 2530385 2530386 2530387 MFG DT 03 | $50.0K | 1 |
| RIVAROXABAN 15MG FC TABLETS RIVAROXABAN 2X14 T 1 NOS 1 PACK B NO 2530383MFG DT 03 25 EXP DT 02 28 | $41.0K | 1 |
| RIVAROXABAN 10 MG FC TABLETS(3X10T)BL (RIVAROXABAN) B.NO 2431205 (1 NOS=1 PACKS)AS PER INV | $32.4K | 1 |
| RIVAROXABAN 15 MG FC TABLETS(2X14T)BL (RIVAROXABAN )(2X14)(1NOS=1PACKS) B.NO. 2331072,73 AS PER INV | $29.4K | 1 |
| RIVAROXABAN 10 MG FC TABLETS(3X10T)BL (RIVAROXABAN)(3X10)(1 NOS=1 PACKS)B.NO 2331059,2331060,2331061 AS PER INV | $17.5K | 1 |
Unison Pharmaceuticals Private Limited exports 40 distinct Rivaroxaban formulations including tablets, capsules, syrups, and combination drugs. The top formulation is RIVAROXABAN 20 MG FC TABLETS(2X14T)BL (RIVAROXABAN) (2X14)(1 with 1 shipments worth $50.0K.
Regulatory Requirements: Exporting Rivaroxaban to Key Markets
What Unison Pharmaceuticals Private Limited must comply with to export Rivaroxaban to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Unison Pharmaceuticals Private Limited Compare to Nearest Rivaroxaban Exporters?
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | LUPIN LIMITED | $1.2M | 28 | 3 | $44.2K |
| 4 | CARITAS HEALTHCARE PRIVATE LIMITED | $1.1M | 22 | 1 | $50.0K |
| 12 | UNISON PHARMACEUTICALS PRIVATE LIMITED ★ | $1.1M | 41 | 6 | $26.7K |
| 14 | MILAN LABORATORIES (INDIA) PRIVATE LIMITED | $853.4K | 31 | 1 | $27.5K |
| 8 | DR REDDYS LABORATORIES LIMITED | $800.0K | 16 | 5 | $50.0K |
Unison Pharmaceuticals Private Limited ranks #12 among 221 Indian Rivaroxaban exporters. Average shipment value of $26.7K compared to the market average of $166.0K. The closest competitors by value are LUPIN LIMITED and CARITAS HEALTHCARE PRIVATE LIMITED.
Which Indian Ports Ship Rivaroxaban Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,144 | 21.3% |
| DELHI AIR CARGO ACC (INDEL4) | 985 | 18.4% |
| DELHI AIR | 659 | 12.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 635 | 11.8% |
| Bombay Air | 197 | 3.7% |
| NHAVA SHEVA SEA (INNSA1) | 164 | 3.1% |
| Delhi Air | 133 | 2.5% |
| HYDERABAD AIR | 110 | 2.1% |
What Other Cardiovascular Products Does Unison Pharmaceuticals Private Limited Export?
Unison Pharmaceuticals Private Limited also exports these cardiovascular products. Each links to the detailed product page.
About Unison Pharmaceuticals Private Limited
Unison Pharmaceuticals Private Limited exports 4 products worth $10.6M. Beyond Rivaroxaban, top products include Ezetimibe, Apixaban, Terbinafine. View the complete Unison Pharmaceuticals Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Rivaroxaban — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Rivaroxaban shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Unison Pharmaceuticals Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 41 individual customs records matching Unison Pharmaceuticals Private Limited exporting Rivaroxaban, covering 40 formulations to 6 countries via 7 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 115+ countries, 497+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Rivaroxaban Export Data from Unison Pharmaceuticals Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Unison Pharmaceuticals Private Limited's Rivaroxaban exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Unison Pharmaceuticals Private Limited
Full Company Profile →
4 products · $10.6M total trade · 3 categories
Rivaroxaban Stats
Company Overview
Top Products by Unison Pharmaceuticals Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Unison Pharmaceuticals Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Rivaroxaban. For current shipment-level data, contact TransData Nexus.